Comparison between Quest Laboratories IPO and Veritaas Advertising IPO.
Quest Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Veritaas Advertising IPO is a SME Bookbuilding proposed to list at NSE SME.
| Quest Laboratories IPO | Veritaas Advertising IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Shreni Shares Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | Rikhav Securities Ltd. | Horizon Financial Consultants Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Quest Laboratories IPO is up to ₹40.95 Cr whereas the issue size of the Veritaas Advertising IPO is up to ₹8.06 Cr. The final issue price of Quest Laboratories IPO is ₹97.00 per share and of Veritaas Advertising IPO is ₹114.00 per share.
| Quest Laboratories IPO | Veritaas Advertising IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹93.00 per share | ₹109.00 per share |
| Issue Price (Upper) | ₹97.00 per share | ₹114.00 per share |
| Issue Price (Final) | ₹97.00 per share | ₹114.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 42,21,600 shares | 7,06,800 shares |
| Fresh Issue Size (Amount) | up to ₹40.95 Cr | up to ₹8.06 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 42,21,600 shares | 7,06,800 shares |
| Issue Size Total (Amount) | up to ₹40.95 Cr | up to ₹8.06 Cr |
Quest Laboratories IPO opens on May 15, 2024, while Veritaas Advertising IPO opens on May 13, 2024. The closing date of Quest Laboratories IPO and Veritaas Advertising IPO is May 17, 2024, and May 15, 2024, respectively.
| Quest Laboratories IPO | Veritaas Advertising IPO | |
|---|---|---|
| Anchor Bid Date | May 14, 2024 | May 10, 2024 |
| Issue Open | May 15, 2024 | May 13, 2024 |
| Issue Close | May 17, 2024 | May 15, 2024 |
| Basis Of Allotment (Tentative) | May 21, 2024 | May 16, 2024 |
| Initiation of Refunds (Tentative) | May 22, 2024 | May 17, 2024 |
| Credit of Share (Tentative) | May 22, 2024 | May 17, 2024 |
| Listing date (Tentative) | May 23, 2024 | May 21, 2024 |
| Anchor Lockin End date 1 | Jun 20, 2024 | Jun 15, 2024 |
| Anchor Lockin End date 2 | Aug 19, 2024 | Aug 14, 2024 |
Quest Laboratories IPO P/E ratio is 23.03, as compared to Veritaas Advertising IPO P/E ratio of 54.
| Quest Laboratories IPO | Veritaas Advertising IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Quest Laboratories Limited Financial Information (Restated)Quest Laboratories Limited's revenue increased by 3.9% and profit after tax (PAT) rose by 22.5% between the financial year ending with March 31, 2023 and March 31, 2022.
| Veritaas Advertising Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.36 | 88.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.82 | 88.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 23.03 | 54 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹158.96 Cr. | ₹32.18 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.03% | 44.24% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 41.86% | 39.65% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | 0.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.21 | ₹2.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 34.03% | 44.23% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Quest Laboratories IPO Retail Individual Investors (RII) are offered 14,98,800 shares while in Veritaas Advertising IPO retail investors are offered 14,98,800 shares. Qualified Institutional Buyers (QIB) are offered 8,31,600 shares in Quest Laboratories IPO and 1,77,600 shares in Veritaas Advertising IPO.
| Quest Laboratories IPO | Veritaas Advertising IPO | |
|---|---|---|
| Anchor Investor Reserveration | 12,36,000 shares | 1,74,000 shares |
| Market Maker Reserveration | 2,28,000 shares | 37,200 shares |
| QIB | 8,31,600 shares | 1,77,600 shares |
| NII | 6,55,200 shares | 1,06,800 shares |
| RII | 14,98,800 shares | 2,48,400 shares |
| Employee | ||
| Others | ||
| Total | 42,21,600 shares | 7,06,800 shares |
Quest Laboratories IPO subscribed 85.26x in total, whereas Veritaas Advertising IPO subscribed 621.62x.
| Quest Laboratories IPO | Veritaas Advertising IPO | |
|---|---|---|
| QIB (times) | 57.20x | 102.41x |
| NII (times) | 184.10x | 629.56x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 57.63x | 989.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 85.26x | 621.62x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
